TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29184891

Group type: EXPERIMENTAL
Intervention: Mobile phone equipped with FrontlineSMS based application in intervention woredas (Ezha and Abeshge)
Number of subjects: 3240

Group type: EXPERIMENTAL
Intervention: Mobile phone equipped with FrontlineSMS based application in Ezha woreda
Number of subjects: 3240

Group type: EXPERIMENTAL
Intervention: Mobile phone equipped with FrontlineSMS based application in all intervention woredas
Number of subjects: 3240

Group type: COMPARATOR
Intervention: Control group (no mobile intervention)
Number of subjects: 3240
Study: 26212846

Group type: EXPERIMENTAL
Intervention: Simplified sleep restriction (SSR)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (sleep hygiene advice alone)
Number of subjects: 97
Study: 23329119

Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Regression group
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Stability group
Number of subjects: 25
Study: 22145506

Group type: EXPERIMENTAL
Intervention: Portable vacuum dressing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional wall vacuum dressing
Number of subjects: 30
Study: 19506005

Group type: EXPERIMENTAL
Intervention: Home-based task-oriented exercise programme (sit-to-stand and step-up exercise) for six weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular daily activities
Number of subjects: 20
Study: 17045894

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acids (PUFA) 2 g/die
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12740675

Group type: EXPERIMENTAL
Intervention: 30 mg sodium hyaluronate (Na HA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 40 mg 6‐methylprednisolone acetate (6‐MPA)
Number of subjects: 60
Study: 11126257

Group type: EXPERIMENTAL
Intervention: Intralipid (200 mg/ml) intravenously as a bolus injection (0.5 ml/kg) over 10 min and thereafter as a continuous intravenous infusion (90 ml/h) for 4 h combined with heparin (200 U/h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline instead of Intralipid and heparin
Number of subjects: 11
Study: 9133082

Group type: COMPARATOR
Intervention: No adjuvant treatment (control)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CMF modality)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Tamoxifen (Tam)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Combined therapy with CMF and Tam
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol
Number of subjects: 539
Study: 8329784

Group type: EXPERIMENTAL
Intervention: Four temazepam 7.5‐mg capsules
Number of subjects: 26

Group type: COMPARATOR
Intervention: One temazepam 30‐mg capsule
Number of subjects: 26
Study: 3562198

Group type: EXPERIMENTAL
Intervention: Precued hand condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Precued direction condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Precued midline condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal group (control)
Number of subjects: 60
Study: 31775146

Group type: EXPERIMENTAL
Intervention: Transcorneal electrical stimulation (TES) applied weekly for 6 months on 1 eye
Number of subjects: 105
Study: 29492907

Group type: EXPERIMENTAL
Intervention: Laparoscopic total gastrectomy (LTG)
Number of subjects: 0
Study: 27319363

Group type: EXPERIMENTAL
Intervention: Conventional round stool
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Round stool with backrest
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Saddle chair with backrest
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Capisco chair
Number of subjects: 4
Study: 24954936

Group type: COMPARATOR
Intervention: Classroom delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online delivery
Number of subjects: 0
Study: 22869834

Group type: EXPERIMENTAL
Intervention: Culturally tailored, family-centered behavioral intervention (Salud Con La Familia program) consisting of 12 weekly 90-minute sessions
Number of subjects: 106

Group type: COMPARATOR
Intervention: Alternative school-readiness program
Number of subjects: 106
Study: 20163347

Group type: EXPERIMENTAL
Intervention: Chromium-nicotinate 400 microg/day for 16 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 18474395

Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15699832

Group type: EXPERIMENTAL
Intervention: Polymyxin/tobramycin alone (n = 130)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Mupirocin/chlorhexidine alone (n = 130)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Both regimens (n = 129)
Number of subjects: 515

Group type: COMPARATOR
Intervention: All placebos (n = 126)
Number of subjects: 515
Study: 12577162

Group type: EXPERIMENTAL
Intervention: Esketamine group (n=21; induction with 0.5 mg/kg BW esketamine and 1.5 mg/kg BW methohexitone)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sevoflurane group (n=21; induction with 1.5-2.0 mg/kg BW methohexitone)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Spinal anaesthesia group (n=22; 2.6-3.0 ml isobaric bupivacaine 0.5%)
Number of subjects: 64
Study: 10495859

Group type: EXPERIMENTAL
Intervention: Nickel sulfate 5 mg (group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 30
Study: 8904748

Group type: EXPERIMENTAL
Intervention: L-dopa 100 mg with benserazide 25 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 1809401

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7140494

Group type: EXPERIMENTAL
Intervention: Cimetidine plus antacids as needed (prn)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo plus prn antacids
Number of subjects: 18
Study: 31690765

Group type: EXPERIMENTAL
Intervention: Putrescine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Spermidine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Spermine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Polyamine concentration of 1 mM
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Polyamine concentration of 4 mM
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Polyamine treatments
Number of subjects: 3
Study: 29806090

Group type: EXPERIMENTAL
Intervention: Induction therapy with golimumab
Number of subjects: 60
Study: 26712960

Group type: EXPERIMENTAL
Intervention: 24-hour quit attempt (blacks)
Number of subjects: 6813

Group type: COMPARATOR
Intervention: 24-hour quit attempt (whites)
Number of subjects: 6813

Group type: EXPERIMENTAL
Intervention: 7-day quit attempt (blacks)
Number of subjects: 6813

Group type: COMPARATOR
Intervention: 7-day quit attempt (whites)
Number of subjects: 6813

Group type: EXPERIMENTAL
Intervention: 6-month continuous abstinence (blacks)
Number of subjects: 6813

Group type: COMPARATOR
Intervention: 6-month continuous abstinence (whites)
Number of subjects: 6813

Group type: EXPERIMENTAL
Intervention: Predictors of 6-month continuous abstinence
Number of subjects: 6813
Study: 24184853

Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT) application in the FAI group
Number of subjects: 28

Group type: COMPARATOR
Intervention: No tape application in the control group
Number of subjects: 28
Study: 22027945

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone (MPA) 10 mg/day for 14 days
Number of subjects: 38
Study: 19278832

Group type: EXPERIMENTAL
Intervention: Bone-borne device
Number of subjects: 46

Group type: COMPARATOR
Intervention: Tooth-borne device
Number of subjects: 46
Study: 17404897

Group type: EXPERIMENTAL
Intervention: Sense of Coherence (SOC)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Mental symptoms (measured by the Symptom Checklist‐90 revised)
Number of subjects: 107
Study: 15081451

Group type: EXPERIMENTAL
Intervention: Drug sedation (group 1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hypnotic sedation (group 2)
Number of subjects: 46
Study: 11701427

Group type: EXPERIMENTAL
Intervention: ACE (acetate infusion with 4 mmol/kg body wt sodium acetate)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HYP (hyperoxia breathing 100% O(2))
Number of subjects: 8

Group type: COMPARATOR
Intervention: CON (saline infusion while breathing room air)
Number of subjects: 8
Study: 9751587

Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Biphasic intermittent positive airway pressure ventilation (BIPAP)
Number of subjects: 20
Study: 7831451

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride (high-dose 3 mg/kg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride (medium-dose 1.5 mg/kg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride (low-dose 0.5 mg/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2458035

Group type: EXPERIMENTAL
Intervention: Human surfactant treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both treatment groups (human surfactant and control)
Number of subjects: 46
Study: 29459986

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200 to 400 mg) for 12 months
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200 to 400 mg)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 27054571

Group type: EXPERIMENTAL
Intervention: CHRNA4 SNPs (specifically rs1044396 and rs1044397)
Number of subjects: 1705

Group type: EXPERIMENTAL
Intervention: N100 amplitude reduction
Number of subjects: 1705
Study: 25330500

Group type: EXPERIMENTAL
Intervention: Off-label DES use (n=1,033)
Number of subjects: 1387

Group type: COMPARATOR
Intervention: On-label DES use (n=354)
Number of subjects: 1387
Study: 23772804

Group type: EXPERIMENTAL
Intervention: Physical activity + weight loss (PA + WL)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Physical activity (PA)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Successful aging (SA) health education
Number of subjects: 288
Study: 21955429

Group type: EXPERIMENTAL
Intervention: Magnetic endoscope imaging (MEI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 1000
Study: 18556139

Group type: EXPERIMENTAL
Intervention: Low dose alcohol (.04%)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: High dose alcohol (.08%)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control (no alcohol)
Number of subjects: 161
Study: 16622641

Group type: EXPERIMENTAL
Intervention: Triclosan dentifrice (Blend‐a‐Med Complete Night)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Triclosan dentifrice plus tongue brushing
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Triclosan dentifrice
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control dentifrice (Crest Cavity Protection)
Number of subjects: 29
Study: 12748864

Group type: EXPERIMENTAL
Intervention: Cycling exercise
Number of subjects: 34

Group type: COMPARATOR
Intervention: Treadmill exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RPE-L (Legs)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RPE-O (Overall)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RPE-C (Breathing/Chest)
Number of subjects: 34
Study: 10673523

Group type: COMPARATOR
Intervention: White children
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: African-American (AA) children
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Spanish surname (SS) children
Number of subjects: 518
Study: 8879097

Group type: EXPERIMENTAL
Intervention: HAV vaccine (1440 EL.U.)
Number of subjects: 110

Group type: COMPARATOR
Intervention: HAV vaccine plus YF vaccine
Number of subjects: 110

Group type: COMPARATOR
Intervention: YF vaccine
Number of subjects: 110
Study: 1513960

Group type: EXPERIMENTAL
Intervention: Model plus verbal rehearsal
Number of subjects: 60

Group type: COMPARATOR
Intervention: Verbal rehearsal only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Model only
Number of subjects: 60
Study: 6434422

Group type: EXPERIMENTAL
Intervention: Nutritional support with carbohydrate application adjusted to O2-consumption
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nutritional support with various infusion regimens
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nutritional support with increased amino-acid intake
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Balanced delivery of energy-yielding substrates
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3-methylhistidine excretion in urine
Number of subjects: 40
Study: 30677485

Group type: EXPERIMENTAL
Intervention: MyHEART intervention (multi‐component, theoretically‐based program for hypertension self-management)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: MyHEART intervention
Number of subjects: 310
Study: 29543891

Group type: EXPERIMENTAL
Intervention: Serious Game (SG) intervention
Number of subjects: 73
Study: 26481177

Group type: EXPERIMENTAL
Intervention: Cochlear implant programming for 12 weeks postoperatively or after tinnitus occurrence
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control subgroup
Number of subjects: 234
Study: 24976987

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (individualized education and telephone counseling for 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 22189066

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 21059444

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg/day
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 18043428

Group type: COMPARATOR
Intervention: Surgical implantation of an investigational epidural electrode over the posterior superior temporal gyrus with functional magnetic resonance imaging targeting, followed by a 2-week stimulation period alternating with a 2-week sham period, and then continuous stimulation.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Continuous chronic stimulation of the secondary auditory cortex.
Number of subjects: 8
Study: 15833901

Group type: EXPERIMENTAL
Intervention: Bogus behavior feedback with biased scanning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bogus behavior feedback with consideration of undesirable outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different behavioral paradigm and field study
Number of subjects: 0
Study: 12523876

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 729

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 729
Study: 9820261

Group type: EXPERIMENTAL
Intervention: Standardized acupuncture regimen (SAR)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Amitriptyline (75 mg/d)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control points (for acupuncture comparison)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (for amitriptyline comparison)
Number of subjects: 250
Study: 7674695

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HMG coenzyme‐A reductase inhibitors
Number of subjects: 0
Study: 2620672

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg
Number of subjects: 99
Study: 98801

Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 22
Study: 29632254

Group type: EXPERIMENTAL
Intervention: VIP 0-3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VIP 3-5
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined VIP 0-3 and VIP 3-5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control 0-3 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control 3-5 years
Number of subjects: 0
Study: 28448397

Group type: EXPERIMENTAL
Intervention: IV pentazocine (15 mg, 1 mL)
Number of subjects: 119

Group type: COMPARATOR
Intervention: IV saline (1 mL)
Number of subjects: 119
Study: 25743386

Group type: EXPERIMENTAL
Intervention: Medically-qualified doctors with early breast cancer
Number of subjects: 276

Group type: COMPARATOR
Intervention: Matched control patients with early breast cancer
Number of subjects: 276
Study: 23438351

Group type: EXPERIMENTAL
Intervention: Early visit to a doctor
Number of subjects: 173

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 173
Study: 20940647

Group type: EXPERIMENTAL
Intervention: Agonist/Antagonist (AA) training group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alternated Strength Training (AST) group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study: 18787361

Group type: EXPERIMENTAL
Intervention: Cognitive intervention consisting of group sessions focused on recollecting specific events and personal identity exercises.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 0
Study: 16801509

Group type: EXPERIMENTAL
Intervention: Adjusted standard-dose warfarin sodium
Number of subjects: 17833

Group type: EXPERIMENTAL
Intervention: Adjusted low-dose warfarin
Number of subjects: 17833

Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 17833

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 17833

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17833
Study: 14585520

Group type: EXPERIMENTAL
Intervention: Estradot 2.5 cm²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradot 3.75 cm²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradot 5.0 cm²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradot 10.0 cm²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradot (all doses)
Number of subjects: 0
Study: 10903016

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg(‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Rocuronium omitted
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.45 mg kg(‐1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg kg(‐1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg kg(‐1) followed by neostigmine 40 microg kg(‐1) and atropine 20 microg kg(‐1)
Number of subjects: 120
Study: 8923336

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1560167

Group type: EXPERIMENTAL
Intervention: Conventional plus 22 minutes of interactive computer‐assisted instruction
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional instruction (counseling and written instruction)
Number of subjects: 52
Study: 6371225

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30621828

Group type: EXPERIMENTAL
Intervention: Intermediate to high risk for OSA (modified STOP‐BANG score ≥ 3)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Low risk for OSA (score < 3)
Number of subjects: 222
Study: 29194899

Group type: EXPERIMENTAL
Intervention: Financial reimbursement
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Training and support
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: AUDIT-C screening tool
Number of subjects: 746
Study: 27064456

Group type: EXPERIMENTAL
Intervention: $800 reward contingent on sustained abstinence from smoking
Number of subjects: 2538

Group type: EXPERIMENTAL
Intervention: $150 refundable deposit plus a $650 reward
Number of subjects: 2538

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2538
Study: 24462505

Group type: EXPERIMENTAL
Intervention: Proton magnetic resonance spectroscopy (1H-MRS) and transcranial magnetic stimulation (TMS) in concussed athletes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Proton magnetic resonance spectroscopy (1H-MRS) and transcranial magnetic stimulation (TMS) in control athletes
Number of subjects: 30
Study: 22540996

Group type: EXPERIMENTAL
Intervention: CEL-100 videolaryngoscope
Number of subjects: 170
Study: 19804954

Group type: EXPERIMENTAL
Intervention: Higher glycemic index diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lower glycemic index diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Controlled feeding days
Number of subjects: 12
Study: 17397428

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 112

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 112
Study: 15642302

Group type: EXPERIMENTAL
Intervention: Non-spherical polyvinyl alcohol (PVA) 355-500 microm
Number of subjects: 17

Group type: COMPARATOR
Intervention: Trisacryl gelatin microspheres (MS) 700-900 microm
Number of subjects: 17
Study: 12271345

Group type: EXPERIMENTAL
Intervention: Olaflur
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oleaflur
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium fluoride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental fluoride containing hydrolyzed casein
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study: 10097858

Group type: EXPERIMENTAL
Intervention: Intra-arterial 5-FU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-arterial FUdR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic treatment
Number of subjects: 0
Study: 7736673

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1,200 mg/d for 4 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 2202990

Group type: EXPERIMENTAL
Intervention: Contingency recruitment plan
Number of subjects: 0
Study: 7276229

Group type: EXPERIMENTAL
Intervention: 10-30 mg/day molindone
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20-30 mg tranylcypromine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: molindone
Number of subjects: 20

Group type: COMPARATOR
Intervention: tranylcypromine
Number of subjects: 20
Study: 30940890

Group type: EXPERIMENTAL
Intervention: Expanded HbA1c genetic risk score (GRS) with 17 HbA1c-related common variants
Number of subjects: 11935

Group type: EXPERIMENTAL
Intervention: Conservative HbA1c genetic risk score (GRS) by excluding 11 variants
Number of subjects: 11935